Renal Business Today

New England Journal Of Medicine (NEJM)

A Second Chance at a Transplanted Kidney

CHICAGO—When Ray Fearing's body didn't take to the kidney his sister had donated to him, the 27-year-old Illinois man had few options. But doctors approached him with a unique suggestion: Why not try donating the organ to another patient in need? ...More
4 weeks ago
Posted in News, Practice Management
Bariatric Surgery Best for Obese Diabetics

PHILADELPHIA—Bariatric surgery improves glycemic control better than optimal medical therapy alone for obese patients with type 2 diabetes, two randomized trials determined. ...More
March 26, 2012
Posted in News, Clinical & Pharma
Antibody Helps in Rare Kidney Disorder

MedPage Today—According to three case reports, dense-deposit kidney disease regressed consistently over time during treatment with a monoclonal antibody to complement protein C5. ...More
March 22, 2012
Posted in News, Clinical & Pharma
Home Hemo Patients Respond to NEJM Study

In late September, a study in the New England Journal of Medicine found the number of event rates were higher the day after a long interval between dialysis suggesting a benefit of more frequent dialysis.To better understand how people using dialysis felt, RBT asked two ...More
October 12, 2011
Posted in Articles, Practice Management
Two-Day Break from Dialysis Increases Risk

MINNEAPOLIS—Hemodialysis patients are at a heightened risk in the long, 2-day period in between dialysis treatments, according to a study published online Sept. 22 in the New England Journal of Medicine (NEJM). ...More
September 22, 2011
Posted in News, Clinical & Pharma
Shorter Hepatitis C Treatment Effective

CHAPEL HILL, N.C. – A new multinational study found that a 24-week treatment course for hepatitis C that adds telaprevir to peginterferon alfa and ribavirin is just as effective as a 48-week regimen for many patients, according to a study published in the Sept. 15 issue of ...More
September 15, 2011
Posted in News, Clinical & Pharma
Drug Improves Kidney Function in Diabetics

PRAGUE—Type 2 diabetics receiving the drug bardoxolone methyl experiences sustained improvement in their kidney function over the course of a 52-week treatment period, according to a phase 2 study published online June 24 in the New England Journal of Medicine. ...More
June 24, 2011
Posted in News, Clinical & Pharma
Study Identifies Cost-effective Immune Suppressant for Transplants

BIRMINGHAM, Ala.—In the first head-to-head comparison of the three most common drugs used at the time of a kidney transplant to prevent organ rejection, researchers found that the least expensive drug – at one-half to one-fifth the price – is as safe and effective as the ...More
May 19, 2011
Posted in News, Clinical & Pharma
Drug Prevents Type 2 Diabetes in High-Risk Individuals

SAN ANTONIO—A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, according to a study published March 24 in the New England Journal of ...More
March 24, 2011
Posted in News, Clinical & Pharma
Survival Matching Should be Used to Allocate Kidneys

ANN ARBOR, Mich.—Providing kidney transplants to patients with the best probability of longer survival would reduce repeat transplant operations and improve life span after kidney transplant, a University of Michigan researcher said in a commentary published in the March 16 ...More
March 21, 2011
Posted in News, Clinical & Pharma, Government & Regulation